Medlab Clinical is proud to present at the International Precision Medicine Conference 2021, between the 21st and 23rd April 2021
Location - Virtual
Abstract Title : Pain: an opioid epidemic requiring a non-opioid alternative
Precision Medicine (PMED) once synonymous with cancer treatment now has potential in a vaster field including infectious diseases, mental health, and age-related illnesses. Whilst PMED holds such vast promise, current day “pitfalls” include high patient costs, high potential for over diagnosis, data sensitivities (legal, ethical) and time as evidence to support PMED use is still developing, as well as addressing disease co-morbidities that can significantly influence patient health outcomes and/or ongoing compliance. For PMED to realise its potential in human healthcare, equal consideration for addressing disease comorbidities, such as pain must be addressed. Pain today continues to represent a significant problem in both physician and patient centres. Current opioid use has had a long effective analgesic history but within the last decade, concerns have been raised over heightened abuse and toxicity profile suggesting a strong need for effective non-opioid analgesic alternatives.